-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

The 2020 Pandemic: Latest Insights on COVID-19

PhD Trainee
Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Coronaviruses, SARS-CoV-2/COVID-19
Sunday, December 6, 2020: 9:30 AM-11:00 AM
Chair:
Robert Brodsky, MD, Johns Hopkins University
Disclosures:
No relevant conflicts of interest to declare.
Panelist:
Saskia Middeldorp, MD, PhD, University of Amsterdam
Disclosures:
Middeldorp: AbbVie: Honoraria; Portola: Honoraria; Pfizer: Honoraria, Research Funding; Boehringer Ingelheim: Honoraria, Research Funding; Bayer: Honoraria, Research Funding; BMS/Pfizer: Honoraria.
Session Introduction

Robert Brodsky, MD

Johns Hopkins University, Baltimore, MD
Do COVID-19 Patients Face Increased Risk of Thrombosis?

Saskia Middeldorp, MD, PhD

University of Amsterdam, Amsterdam, Netherlands
How Can Community-Based Surveillance Strategies for Sars-Cov-2 Inform Pandemic Planning?

Helen Chu, MD, MPH

University of Washington, Seattle, WA
Promise in Plasma? What is the Experience using Convalescent Plasma to Treat SARS-CoV-19?

Evan Bloch, MD, MS

Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University, Baltimore, MD
Live Q&A and Panel Discussion

Saskia Middeldorp, MD, PhD

University of Amsterdam, Amsterdam, Netherlands
See more of: Special-Interest Sessions
<< Previous Session | Next Session >>